Shares in Invitrogen tumbled 14.44 percent for the tracking period ended Tuesday, leading all decliners in the BCW Index this week. The firm missed Wall Street and internal targets for its third quarter at its BioReliance business continues to struggle (see article in this week's issue). Bruker also had a tough week, with its shares dropping 7.43 percent on the heels of its agreement to acquire an X-ray microanalysis business. On the other end of the spectrum, Molecular Devices gained 15.47 percent after reporting a third-quarter profit and 9-percent revenue growth for the third quarter. Shares in Applied Biosystems and PerkinElmer also posted strong gains during the past week. Overall, the BCW Index declined .9 percent, compared to a .3-percent increase for the Dow Jones Industrial Average, the Nasdaq inched up .2 percent, and the Nasdaq Biotech Index lost 1.7 percent.
|
BioCommerce Week Index of Diversified Molecular Biology Tool Companies
|
||||
| Company |
Ticker
|
Current Price
(Nov. 1, 2005) |
Last Price
(Oct. 25, 2005) |
% change
|
| Agilent |
A
|
32.13
|
31.18
|
3.05
|
| Applied Biosystems |
ABI
|
24.97
|
23.35
|
6.94
|
| Beckman |
BEC
|
49.5
|
50.47
|
-1.92
|
| Bio-Rad |
BIO
|
57.26
|
55.57
|
3.04
|
| Bruker |
BRKR
|
4.11
|
4.44
|
-7.43
|
| Fisher Scientific |
FSH
|
56.64
|
58.16
|
-2.61
|
| GE |
GE
|
33.6
|
33.91
|
-0.91
|
| Harvard Bio |
HBIO
|
3.17
|
3.12
|
1.60
|
| Invitrogen |
IVGN
|
63.47
|
74.18
|
-14.44
|
| Molecular Devices |
MDCC
|
22.91
|
19.84
|
15.47
|
| PerkinElmer |
PKI
|
22.1
|
20.82
|
6.15
|
| Qiagen |
QGEN
|
11.92
|
11.86
|
0.51
|
| Sigma |
SIAL
|
64.06
|
63.53
|
0.83
|
| Stratagene |
STGN
|
9.69
|
9.87
|
-1.82
|
| Thermo |
TMO
|
29.75
|
30.7
|
-3.09
|
| Waters |
WAT
|
36.51
|
35.75
|
2.13
|
| BCW Index Average |
32.61
|
32.92
|
-0.94
|
|